Variant report
Variant | esv3479368 |
---|---|
Chromosome Location | chr8:64154290-64156126 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:64147703..64149229-chr8:64153058..64154702,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377541663 | chr8:64154308-64154309 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200798142 | chr8:64154325-64154326 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147563687 | chr8:64154370-64154371 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142598520 | chr8:64154393-64154394 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538225979 | chr8:64154444-64154445 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146909771 | chr8:64154461-64154462 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138957949 | chr8:64154464-64154465 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371073448 | chr8:64154469-64154470 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554350239 | chr8:64154471-64154472 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572304772 | chr8:64154504-64154505 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192649443 | chr8:64154575-64154576 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576235491 | chr8:64154613-64154614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201952227 | chr8:64154642-64154643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569584974 | chr8:64154649-64154650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183213529 | chr8:64154650-64154651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73686731 | chr8:64154653-64154654 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs187539676 | chr8:64154658-64154659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558961378 | chr8:64154751-64154752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368177891 | chr8:64154752-64154753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1435459 | chr8:64154766-64154767 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs2043521 | chr8:64154790-64154791 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs5891893 | chr8:64154803-64154804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192348871 | chr8:64154804-64154805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541738984 | chr8:64154807-64154808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201830067 | chr8:64154821-64154822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151234686 | chr8:64154824-64154825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2043523 | chr8:64154825-64154826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373986040 | chr8:64154826-64154827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569267896 | chr8:64154827-64154828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559633632 | chr8:64154832-64154833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35749623 | chr8:64154846-64154847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184299907 | chr8:64154918-64154919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372201366 | chr8:64154951-64154952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189662911 | chr8:64155006-64155007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537118368 | chr8:64155027-64155028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182692901 | chr8:64155044-64155045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536917374 | chr8:64155056-64155057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550150013 | chr8:64155088-64155089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571507491 | chr8:64155108-64155109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539173690 | chr8:64155143-64155144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374380246 | chr8:64155163-64155164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143784552 | chr8:64155166-64155167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536465283 | chr8:64155191-64155192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:64154000-64155000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:64154200-64154600 | Flanking Active TSS | HepG2 | liver |
3 | chr8:64154200-64154600 | Flanking Active TSS | K562 | blood |
4 | chr8:64155000-64155200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |